1-3 of 3
Biljana Culjkovic-Kraljacic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ribavirin, an eIF4E Inhibitor, As a Potential Anti-Lymphoma Therapeutic - Preclinical and Early Clinical Data

Sarah C. Rutherford, MD, Eric Stewart, MD, Tharu M Fernando, MS, Biljana Culjkovic-Kraljacic, Katherine L. B. Borden, Koen van Besien, MD, Peter Martin, MD, Richard R Furman, MD, John P. Leonard, MD, Leandro Cerchietti, MD
Journal: Blood
Blood (2016) 128 (22): 3045.
https://doi.org/10.1182/blood.V128.22.3045.3045
Published: 2016
Journal Articles

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas

Biljana Culjkovic-Kraljacic, Tharu M. Fernando, Rossella Marullo, Nieves Calvo-Vidal, Akanksha Verma, ShaoNing Yang, Fabrizio Tabbò, Marcello Gaudiano, Hiba Zahreddine, Rebecca L. Goldstein, Jayeshkumar Patel, Tony Taldone, Gabriela Chiosis, Marco Ladetto, Paola Ghione, Rodolfo Machiorlatti, Olivier Elemento, Giorgio Inghirami, Ari Melnick, Katherine L. B. Borden, Leandro Cerchietti
Journal: Blood
Blood (2016) 127 (7): 858–868.
https://doi.org/10.1182/blood-2015-05-645069
Published: 2016
Includes: Supplemental data
Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD
Journal: Blood
Blood (2013) 122 (21): 821.
https://doi.org/10.1182/blood.V122.21.821.821
Published: 2013